Format

Send to

Choose Destination
Biomed Mater Eng. 2017;28(s1):S47-S56. doi: 10.3233/BME-171623.

Mechanobiology of mesenchymal stem cells: Which interest for cell-based treatment?

Author information

1
UMR 7365 CNRS-Université de Lorraine, Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Biopôle, 54500 Vandœuvre-lès-Nancy, France.
2
Université de Lorraine, 54000 Nancy, France.
3
FR3209 CNRS BMCT - Bio-Ingénierie Moléculaire Cellulaire et Thérapeutique, Faculté de Médecine, F-54505 Vandœuvre-lès-Nancy, France.
4
UMR 7563 CNRS-Université de Lorraine, LEMTA, Vandœuvre-lès-Nancy, France.
5
CHU de Nancy, Unité de Thérapie Cellulaire, banque de Tissus, 54500 Vandœuvre-lès-Nancy, France.
6
Department of Pathophysiology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.

Abstract

Thanks to their immune properties, the mesenchymal stem cells (MSC) are a promising source for cell therapy. Current clinical trials show that MSC administrated to patients can treat different diseases (graft-versus-host disease (GVHD), liver cirrhosis, systemic lupus, erythematosus, rheumatoid arthritis, type I diabetes…). In this case, the most common mode of cell administration is the intravenous injection, and the hemodynamic environment of cells induced by blood circulation could interfere on their behavior during the migration and homing towards the injured site. After a brief review of the mechanobiology concept, this paper will help in understanding how the mechanical environment could interact with MSC behavior once they are injected to patient in cell-based treatment.

KEYWORDS:

Mesenchymal stem cells; cell-based treatment; homing; mechanobiology; migration

PMID:
28372277
DOI:
10.3233/BME-171623
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for IOS Press
Loading ...
Support Center